Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-theanine on Motor Cortex Excitability in Healthy Subjects
NCT04749745Phase 1Completed
- Sponsor
- Butler Hospital
- Start
- Jun 2020
- Primary completion
- May 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in major depressive disorder (MDD) comparing L-Theanine First with Placebo First (2 arms). Primary endpoint: Change of Motor Cortex Excitability Measures by ppTMS. Started Jun 2020; status: completed.
02
Drugs
l-theanine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04749745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04749745.